PDPL.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 Aug 2023 @ 10:15):

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc...

Stats
Tagesvolumen	1 063.00
Durchschnittsvolumen	0.00
Marktkapitalisierung	101.08M
EPS	INR7.99 ( 2022-03-31 )
Last Dividend	INR1.125 ( 2010-09-13 )
Next Dividend	INR0 ( N/A )
P/E	-0.110
ATR14	INR0.0200 (0.69%)

Volumen Korrelation

Lang: -0.05 (neutral)

Kurz: 0.00 (neutral)

Signal:(33.266) Neutral

Parenteral Drugs (India) Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Parenteral Drugs (India) Korrelation - Währung/Rohstoff

0.86
( strong )

0.84
( strong )

0.00
( neutral )

0.89
( strong )

-0.05
( neutral )

-0.74
( moderate negative )

Parenteral Drugs (India) Finanzdaten

Annual	2022
Umsatz:	INR84.96M
Bruttogewinn:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2022
Umsatz:	INR84.96M
Bruttogewinn:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2021
Umsatz:	INR121.53M
Bruttogewinn:	INR48.37M (39.80 %)
EPS:	INR-40.82

FY	2020
Umsatz:	INR240.25M
Bruttogewinn:	INR13.40M (5.58 %)
EPS:	INR-38.26

Financial Reports:

No articles found.

Parenteral Drugs (India) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Parenteral Drugs (India) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0762 - No dividend growth expected in the near future

Information

First Dividend	INR1.125	2010-09-13
Last Dividend	INR1.125	2010-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.125	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0762
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TATACONSUM.NS	Dividend Junior	2023-05-19	Annually	26	0.60%
NIPPOBATRY.NS	Dividend Junior	2023-09-20	Annually	23	1.06%
INDIANB.NS	Dividend Junior	2023-06-12	Annually	18	1.99%
CIPLA.NS	Dividend Junior	2023-07-20	Annually	28	0.41%
SANGHVIMOV.NS	Dividend Junior	2023-08-04	Sporadic	18	0.41%
M&MFIN.NS	Dividend Junior	2023-07-20	Annually	19	1.20%
GLOBUSSPR.NS	Dividend Junior	2023-07-14	Sporadic	15	0.36%
ASTEC.NS	No Dividend Player	2023-07-20	Annually	15	0.08%
TIPSINDLTD.NS	Dividend Junior	2023-08-03	Annually	17	0.03%
PEL.NS	Dividend Junior	2023-06-16	Annually	29	1.59%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.99	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.158	1.200	-5.26	-6.31	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0559	0.800	-4.72	-3.78	[1 - 3]
quickRatioTTM	0.00970	0.800	-4.65	-3.72	[0.8 - 2.5]
cashRatioTTM	0.0000001	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0.221	-1.500	6.31	-9.47	[0 - 0.6]
interestCoverageTTM	-0.000519	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0809	-0.162	[0 - 20]
debtEquityRatioTTM	-0.130	-1.500	-0.520	0.781	[0 - 2.5]
grossProfitMarginTTM	0.357	1.000	7.39	7.39	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00649	1.000	-2.13	-2.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00450	1.000	-1.136	-1.136	[0.2 - 2]
assetTurnoverTTM	0.0175	0.800	-3.22	-2.57	[0.5 - 2]
Total Score				-1.062

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.113	1.000	-0.112	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.162	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00111	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0568	1.000	-3.92	0	[0.1 - 0.5]
Total Score				0.0762

Parenteral Drugs (India)

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.